NCDR

Cathie Biga is New American College of Cardiology President

Retrieved on: 
Lunedì, Aprile 8, 2024
College, FACC, Culture, Practice management, NCDR, Science, Trustee, Knowledge, History, Registry, Health policy, MSN, American College, MPH, Multimedia, ACC, Health, MSCE, Nursing

ATLANTA, April 8, 2024 /PRNewswire/ -- Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization's first non-physician president. She will serve a one-year term representing over 56,000 cardiovascular care team members around the world and leading the cardiovascular organization in its mission to transform cardiovascular care and improve heart health for all.

Key Points: 
  • ATLANTA, April 8, 2024 /PRNewswire/ -- Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization's first non-physician president.
  • "The concept of 'standing on the shoulders of giants' is often referenced when talking about leadership changes and transformation over time.
  • She's been a member of the ACC Board of Trustees for six years, most recently serving as vice president.
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

NVIDIA Announces Earth Climate Digital Twin

Retrieved on: 
Lunedì, Marzo 18, 2024
Cloud, Deep learning, Physics, Universal Scene Description, Climate change, GTC, Informatics, GPU, NCDR, Weather Underground (weather service), Intelligence, Meteomatics, Acceleration, SAN, ICON, Climate, News, Death, DGX, Weather, CWA, API, Technology Center, The Weather Company, Nvidia Omniverse, Video game

SAN JOSE, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- GTC -- To accelerate efforts to combat the $140 billion in economic losses due to extreme weather brought on by climate change, NVIDIA today announced its Earth-2 climate digital twin cloud platform for simulating and visualizing weather and climate at unprecedented scale.

Key Points: 
  • SAN JOSE, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- GTC -- To accelerate efforts to combat the $140 billion in economic losses due to extreme weather brought on by climate change, NVIDIA today announced its Earth-2 climate digital twin cloud platform for simulating and visualizing weather and climate at unprecedented scale.
  • “Climate disasters are now normal — historic droughts, catastrophic hurricanes and generational floods appear in the news with alarming frequency,” said Jensen Huang, founder and CEO of NVIDIA.
  • It also includes GPU acceleration of numerical weather prediction models like ICON on the latest NVIDIA Grace Hopper™ systems.
  • Running on NVIDIA DGX GH200, HGX™ H100 and OVX™ supercomputers, Earth-2 may provide a path to simulate and visualize the global climate simulations at unprecedented speed and scale.

EISENHOWER HEALTH EARNS NATIONAL RECOGNITION WITH HeartCARE CENTER DESIGNATION

Retrieved on: 
Mercoledì, Febbraio 28, 2024
TAVR, Hospital, BSN, Aortic stenosis, Resuscitation, Registry, RN, Electrophysiology, MBA, Cardiology, Heart failure, NCDR, American College, Patient, MPH, FACC, Disease, Heart, ACC, Coachella Valley, Accreditation, PCI, Nursing

RANCHO MIRAGE, Calif., Feb. 28, 2024 /PRNewswire/ -- The American College of Cardiology has recognized Eisenhower Health for its demonstrated commitment to comprehensive, high-quality culture and cardiovascular care. Eisenhower Health was awarded the HeartCARE Center National Distinction of Excellence based on meeting accreditation criteria, and through their ongoing performance registry reporting.

Key Points: 
  • Eisenhower Health was awarded the HeartCARE Center National Distinction of Excellence based on meeting accreditation criteria, and through their ongoing performance registry reporting.
  • "We are proud to be the Coachella Valley's only heart program to earn the HeartCARE Center distinction.
  • "ACC Accreditation Services is proud to award Eisenhower Health with the HeartCARE Center designation."
  • Eisenhower Health has proven to be a forward-thinking institution with goals to advance the cause of sustainable quality improvement.

Shimadzu Medical Systems USA installs first TRINIAS SCORE OPERA Cardiac Catheterization Lab in the US

Retrieved on: 
Venerdì, Ottobre 13, 2023
Certification, Hospital, Trinia, American College, American College of Cardiology, PCI, Joint Commission, MHA, Heart, Radiation, Percutaneous coronary intervention, Splenic infarction, Facial muscles, Platinum, Chest pain, MI, Shimadzu, Artery, NCDR, ICD, Stroke, Emergency, Vein, Cardiac catheterization, Blood, Patient, Quality of life, Medical imaging, South Carolina Lowcountry

LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).

Key Points: 
  • LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
  • Shimadzu Medical Systems USA, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12!
  • Beaufort Memorial Hospital marked the 20th anniversary of the Cochrane Heart Center with the opening of its newly renovated cardiac catheterization lab outfitted with the most advanced technology in the nation.
  • These patients require an urgent, minimally invasive stenting procedure called percutaneous coronary intervention (PCI) that is performed in the cath lab.

American College of Cardiology Program to Increase Cholesterol Screenings

Retrieved on: 
Martedì, Settembre 12, 2023
ACC, Amgen, College, Cardiovascular disease, American Heart Association, American College of Cardiology, Registry, Stroke, MACC, FACC, NCDR, Woman, Improvement, Doctor of Philosophy, Health policy, Science, Outline, ECDP, Guideline, Patient, Risk, Practice management, LDL, Knowledge, ASCVD, Moyamoya disease, American College, Health, Medical device, Pharmaceutical industry, Dietary supplement, Nursing, Esperies, MD, Cardiology

WASHINGTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.

Key Points: 
  • The higher a person’s LDL, or “bad” cholesterol, the higher the chance of developing heart disease or having a heart attack or stroke.
  • Evidence has shown that lowering LDL levels through lifestyle changes and/or medications can reduce a person’s risk of atherosclerotic cardiovascular disease (ASCVD).
  • The guideline also recommends using the ASCVD Risk Estimator, which was developed in 2013 and today is the most widely used risk calculator.
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

American College of Cardiology Program to Increase Cholesterol Screenings

Retrieved on: 
Martedì, Settembre 12, 2023
ACC, Amgen, College, Cardiovascular disease, American Heart Association, American College of Cardiology, Registry, Cholesterol, Stroke, MACC, FACC, NCDR, Woman, Multimedia, Improvement, Doctor of Philosophy, Health policy, Practice Fusion, Science, Outline, ECDP, Guideline, Patient, Risk, Practice management, LDL, Knowledge, ASCVD, Moyamoya disease, American College, Health, Medical device, Pharmaceutical industry, Nursing, Esperies, MD, Cardiology

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, "Driving Urgency in LDL Screening," to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.

Key Points: 
  • The higher a person's LDL, or "bad" cholesterol, the higher the chance of developing heart disease or having a heart attack or stroke.
  • Evidence has shown that lowering LDL levels through lifestyle changes and/or medications can reduce a person's risk of atherosclerotic cardiovascular disease (ASCVD).
  • We are proud to have joined forces with the American College of Cardiology and Esperion on this collaborative effort to increase doctor-directed screening and, ultimately, helping to improve cardiovascular care and patient outcomes."
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Retrieved on: 
Sabato, Maggio 20, 2023
Tricuspid valve, Heart Rhythm Society, EU, Freedom, Chosen-ciphertext attack, Heart failure, Pulmonary vein stenosis, Boston Scientific, BSX, Atrial fibrillation, Learning curve, FLX, ICD, NCDR, Catheter ablation, Arrhythmia, DOAC, Atrial tachycardia, Kaplan–Meier estimator, Heart Rhythm, Patient, Molina Healthcare, Physician, Electrophysiology, Data, Risk, LAAC, Diagnosis, Growth, AF, IDE, Ventricular fibrillation, Recurrence, Cardiology, NYSE, Disease, Safety, Journal of the American College of Cardiology, ATLAS, Medical imaging, Pharmaceutical industry, Nursing, Birth control, Medical device

MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21.

Key Points: 
  • All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21.
  • The registry data included favorable single procedure success rates, along with efficient procedure times in a broad patient population.
  • Data demonstrated a predictable workflow with a median of 58 minutes within an interquartile range of 40 to 87 minutes.
  • "The data shared at this year's Heart Rhythm meeting showcases the breadth and depth of our cardiology therapies, which spans from diagnosis to treatment of cardiac disease, and highlights the continued growth of our portfolio," said Kenneth Stein, M.D., senior vice president and global chief medical officer, Boston Scientific.

Evermed, ACC launch ACC Anywhere, the "Netflix of Cardiology"

Retrieved on: 
Mercoledì, Aprile 12, 2023
ACC, College, Registry, FACC, NCDR, MBA, Research, Cardiology, Health policy, Science, Organization, Patient, Knowledge, American College, Health, Netflix, Education, Nursing, MD

ACC Anywhere is a new content hub that provides cardiologists with on-demand access to the latest clinical knowledge.

Key Points: 
  • ACC Anywhere is a new content hub that provides cardiologists with on-demand access to the latest clinical knowledge.
  • Evermed was selected to collaborate with ACC due to its advanced AI-powered recommender engine and its ability to effectively deliver medical education content 365 days per year.
  • To learn more about ACC Anywhere, which is available to health care providers around the world, visit www.acc.org/accanywhere .
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

Dr. B. Hadley Wilson is New American College of Cardiology President

Retrieved on: 
Lunedì, Marzo 6, 2023
Wake Forest School of Medicine, Registry, Science, Health, College, Davidson College, American College of Cardiology, FACC, Cardiovascular disease, Education, RN, Duke University School of Medicine, Florida Board of Governors, Cardiology, Catheter, Patient, Multimedia, Wilson, MSN, Medical missions, Knowledge, Health policy, Vanderbilt University, Doctor of Philosophy, NCDR, American College, Internal medicine, ACC, Nursing, Dentistry, MD, Trustee

NEW ORLEANS, March 6, 2023 /PRNewswire/ -- B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology.

Key Points: 
  • NEW ORLEANS, March 6, 2023 /PRNewswire/ -- B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology.
  • B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology.
  • After completing his cardiology fellowship, Wilson joined Sanger Heart and Vascular Institute as an interventional cardiologist and served as director of the catheterization laboratory and chief of cardiology for 15 years.
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

Retrieved on: 
Martedì, Settembre 6, 2022
Security (finance), Technology, LAA, Securities Exchange Act of 1934, NYSE, Safety, BSX, Securities Act of 1933, Warfarin, Boston Scientific, Food and Drug Administration, Time, Exercise, DAPT, Boston, Risk, Left atrial appendage occlusion, NCDR, CT, Drug Quality and Security Act, Food, Physician, American College, Science, Forward-looking statement, NVAF, FLX, U.S. Securities and Exchange Commission, Aspirin, OAC, Intention, ACCF, FDA, Twitter, Ventricular fibrillation, Intellectual property, Annual report, LAAC, Health, Life, Patient, Pharmaceutical industry, Medical device, Part Two, Facebook, Amulet

MARLBOROUGH, Mass., Sept. 6, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling for the current-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device to include a 45-day dual anti-platelet therapy (DAPT) option as an alternative to 45-day oral anticoagulation (OAC) plus aspirin for post-procedural treatment of patients with non-valvular atrial fibrillation (NVAF).

Key Points: 
  • "This significant step forward is supported by the robust safety and efficacy profile demonstrated by both the legacy WATCHMAN and current-generation WATCHMAN FLX technologies."
  • The labeling in Europe has included the choice of either OAC or a DAPT post-procedural drug regimen for WATCHMAN technology since 2017.
  • Ongoing studies with the WATCHMAN FLX device include the CHAMPION-AF and OPTION clinical trials to evaluate use of the device for broader patient populations with NVAF.
  • Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.